P1 · PANEL / ROI / AXIS GROUND TRUTH
原 EXE 对齐基准真值复核
所有保存均写入追加式审计事件;旧标注、旧比较和旧提取结果不会被删除或覆盖。
low_resolution_complex
pending
PMID 42436879
Ten-day decitabine vs "3+7" in patients with AML aged ≥60 years: long-term results of the randomized phase 3 EORTC trial AML21.
fig1 · Panel E · Time to progression from allo-HSCT
Figure 1. Survival endpoints. Similar outcomes in both treatment groups from randomization (A-B) and from time of allografting (C-F). The marks on the plot indicate censoring of individual patients. HR estimates and P values are based on a Cox model adjusted for the stratification factors used at randomization (age and AML type). Allo-HSCT, allogeneic HSCT; N, number of patients.坐标框复核
洋红 = 当前 Linux 候选;绿色 = 已保存人工真值。没有绿色框表示仍未形成真值。
当前候选 {'x0': 72, 'y0': 34, 'x1': 354, 'y1': 197}
人工真值 {'x0': 72, 'x1': 354, 'y0': 34, 'y1': 197}
查看候选 OCR 与警告(只能作种子,不能自证真值)
{
"complete": false,
"engine": "RapidOCR",
"plot_bottom": 307,
"plot_left": 0,
"plot_right": 357,
"plot_top": 0,
"warnings": [
"insufficient_x_ticks",
"insufficient_y_ticks"
],
"x_axis_y": 307,
"x_confidence": 0.0,
"x_detected": false,
"x_max": null,
"x_min": null,
"x_ticks": [],
"y_axis_x": 0,
"y_confidence": 0.0,
"y_detected": false,
"y_max": null,
"y_min": null,
"y_ticks": []
}
追加一条审查结论
选择“有效 KM”时,四边 ROI、四个坐标范围、Panel、终点和曲线数均为必填。
追加式审计历史
最新事件仅作为当前缓存;以下每一条既往结论都永久保留。
| 事件 | 时间 / 审查人 | 状态 | ROI | 坐标 | 说明 |
|---|---|---|---|---|---|
| #108p1-visual-axis-audit-v2 · frozen benchmark contact sheets + original images + RapidOCR re-audit | 2026-07-28T15:12:18+00:00Codex-assisted visual audit | valid_km | {'x0': 72, 'x1': 354, 'y0': 34, 'y1': 197} |
X 0.0–9.0 / Y 0.0–100.0 |
P1 冻结原图审查;人工检查冻结原图刻度;ROI 四边按可见坐标轴框记录。 |
最近一次正式比较
Suite #3 · 2026-07-28T15:15:12+00:00
真值完整 117 / 120;通过 0;缺真值 0;无效案例 3。



